期刊文献+

CHOP-BME方案治疗非何杰金型恶性淋巴瘤近期临床观察 被引量:1

Clinical Observation of Non-Hodgkin's Lymphoma Treated with CHOP-BME
在线阅读 下载PDF
导出
摘要 应用 CHOP-BME 方案序贯给药治疗34例非何杰金型淋巴瘤,中高度恶性者30例(88.2%),总缓解率为93.8%,完全缓解率为58.6%。主要毒副反应为消化道反应,白细胞降低及脱发,但均不严重,少部分病人出现转氨酶升高及心电图改变。 The paper reports 34 cases of non-Hodgkin's lymphoma that were treated by CHOP-BME chemotherapy regimen.The patients were confirmed all by pathologic diagnosis.According of 1985 Chendu meet's classifications schedule of non-Hodgkin's lymphoma conducted classification,thirty of 34 cases were intermediate grade and high grade malignancy.The treatment time were all over 3 courses. The treatment results:total remission rate was 93.8%,and complete remission rate was 58.6%. The main side effects were gastrointestinal toxicity,dropping of WBC and trichomadesis.But the side effects were not severe.A few patients had SGPT rising and ECG changing.
出处 《河南肿瘤学杂志》 1993年第2期125-127,共3页 Henan Journal of Oncology
关键词 淋巴瘤 药物疗法 chomtherapy non-Hodgkin's malignant lymphoma
  • 相关文献

参考文献2

  • 1江伟,祝浩强,张一欧,宋依霖,柯金陵,王晓波.CHOP与BEPPA交替治疗进展型恶性淋巴瘤17例近期疗效观察[J]癌症,1991(06).
  • 2黄雪珍,黄诚,毛雪华,张淑端,赵寿祥,陈钦恭.Vp16-213为主的联合方案治疗难治性恶性淋巴瘤16例近期疗效分析[J]癌症,1989(06).

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部